<?xml version='1.0' encoding='utf-8'?>
<document id="29702137"><sentence text="Reduced clearance of venlafaxine in a combined treatment with quetiapine."><entity charOffset="21-32" id="DDI-PubMed.29702137.s1.e0" text="venlafaxine" /><entity charOffset="62-72" id="DDI-PubMed.29702137.s1.e1" text="quetiapine" /><pair ddi="false" e1="DDI-PubMed.29702137.s1.e0" e2="DDI-PubMed.29702137.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29702137.s1.e0" e2="DDI-PubMed.29702137.s1.e1" /></sentence><sentence text="Venlafaxine and the atypical antipsychotic quetiapine are often administered concomitantly"><entity charOffset="0-11" id="DDI-PubMed.29702137.s2.e0" text="Venlafaxine" /><entity charOffset="43-53" id="DDI-PubMed.29702137.s2.e1" text="quetiapine" /><pair ddi="false" e1="DDI-PubMed.29702137.s2.e0" e2="DDI-PubMed.29702137.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29702137.s2.e0" e2="DDI-PubMed.29702137.s2.e1" /></sentence><sentence text=" Both drugs share several metabolic hepatic pathways" /><sentence text=" However, pharmacokinetic interactions between venlafaxine and quetiapine have not been studied yet"><entity charOffset="47-58" id="DDI-PubMed.29702137.s4.e0" text="venlafaxine" /><entity charOffset="63-73" id="DDI-PubMed.29702137.s4.e1" text="quetiapine" /><pair ddi="false" e1="DDI-PubMed.29702137.s4.e0" e2="DDI-PubMed.29702137.s4.e0" /><pair ddi="false" e1="DDI-PubMed.29702137.s4.e0" e2="DDI-PubMed.29702137.s4.e1" /></sentence><sentence text=" A therapeutic drug monitoring database containing serum concentrations of venlafaxine (VEN) and its active metabolite O-desmethylvenlafaxine (ODVEN) was analyzed"><entity charOffset="75-86" id="DDI-PubMed.29702137.s5.e0" text="venlafaxine" /><entity charOffset="88-91" id="DDI-PubMed.29702137.s5.e1" text="VEN" /><entity charOffset="119-141" id="DDI-PubMed.29702137.s5.e2" text="O-desmethylvenlafaxine" /><entity charOffset="145-166" id="DDI-PubMed.29702137.s5.e3" text="VEN" /><pair ddi="false" e1="DDI-PubMed.29702137.s5.e0" e2="DDI-PubMed.29702137.s5.e0" /><pair ddi="false" e1="DDI-PubMed.29702137.s5.e0" e2="DDI-PubMed.29702137.s5.e1" /><pair ddi="false" e1="DDI-PubMed.29702137.s5.e0" e2="DDI-PubMed.29702137.s5.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s5.e0" e2="DDI-PubMed.29702137.s5.e3" /><pair ddi="false" e1="DDI-PubMed.29702137.s5.e1" e2="DDI-PubMed.29702137.s5.e1" /><pair ddi="false" e1="DDI-PubMed.29702137.s5.e1" e2="DDI-PubMed.29702137.s5.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s5.e1" e2="DDI-PubMed.29702137.s5.e3" /><pair ddi="false" e1="DDI-PubMed.29702137.s5.e2" e2="DDI-PubMed.29702137.s5.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s5.e2" e2="DDI-PubMed.29702137.s5.e3" /></sentence><sentence text=" Two groups of patients were compared: venlafaxine monotherapy V0 (n = 153) and co-medication with quetiapine, VQUE (n = 71)"><entity charOffset="39-50" id="DDI-PubMed.29702137.s6.e0" text="venlafaxine" /><entity charOffset="99-109" id="DDI-PubMed.29702137.s6.e1" text="quetiapine" /><entity charOffset="111-115" id="DDI-PubMed.29702137.s6.e2" text="VQUE" /><pair ddi="false" e1="DDI-PubMed.29702137.s6.e0" e2="DDI-PubMed.29702137.s6.e0" /><pair ddi="false" e1="DDI-PubMed.29702137.s6.e0" e2="DDI-PubMed.29702137.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29702137.s6.e0" e2="DDI-PubMed.29702137.s6.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s6.e1" e2="DDI-PubMed.29702137.s6.e1" /><pair ddi="false" e1="DDI-PubMed.29702137.s6.e1" e2="DDI-PubMed.29702137.s6.e2" /></sentence><sentence text=" Serum concentrations of VEN, ODVEN, and active moiety, AM (VEN + ODVEN), metabolite to parent compound ratio (ODVEN/VEN) and dose adjusted serum concentrations were compared using non-parametrical tests without information on CYP2D6 genotype"><entity charOffset="25-28" id="DDI-PubMed.29702137.s7.e0" text="VEN" /><entity charOffset="32-34" id="DDI-PubMed.29702137.s7.e1" text="VEN" /><entity charOffset="60-62" id="DDI-PubMed.29702137.s7.e2" text="VEN" /><entity charOffset="68-70" id="DDI-PubMed.29702137.s7.e3" text="VEN" /><entity charOffset="113-115" id="DDI-PubMed.29702137.s7.e4" text="VEN" /><entity charOffset="117-119" id="DDI-PubMed.29702137.s7.e5" text="VEN" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e0" e2="DDI-PubMed.29702137.s7.e0" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e0" e2="DDI-PubMed.29702137.s7.e1" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e0" e2="DDI-PubMed.29702137.s7.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e0" e2="DDI-PubMed.29702137.s7.e3" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e0" e2="DDI-PubMed.29702137.s7.e4" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e0" e2="DDI-PubMed.29702137.s7.e5" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e1" e2="DDI-PubMed.29702137.s7.e1" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e1" e2="DDI-PubMed.29702137.s7.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e1" e2="DDI-PubMed.29702137.s7.e3" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e1" e2="DDI-PubMed.29702137.s7.e4" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e1" e2="DDI-PubMed.29702137.s7.e5" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e2" e2="DDI-PubMed.29702137.s7.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e2" e2="DDI-PubMed.29702137.s7.e3" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e2" e2="DDI-PubMed.29702137.s7.e4" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e2" e2="DDI-PubMed.29702137.s7.e5" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e3" e2="DDI-PubMed.29702137.s7.e3" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e3" e2="DDI-PubMed.29702137.s7.e4" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e3" e2="DDI-PubMed.29702137.s7.e5" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e4" e2="DDI-PubMed.29702137.s7.e4" /><pair ddi="false" e1="DDI-PubMed.29702137.s7.e4" e2="DDI-PubMed.29702137.s7.e5" /></sentence><sentence text=" The two groups did not differ in terms of the daily dosage of venlafaxine, age, or sex"><entity charOffset="63-74" id="DDI-PubMed.29702137.s8.e0" text="venlafaxine" /></sentence><sentence text=" Median serum concentrations in the quetiapine group showed significantly, 15"><entity charOffset="36-46" id="DDI-PubMed.29702137.s9.e0" text="quetiapine" /></sentence><sentence text="8% and 29" /><sentence text="3% higher values for AM and ODVEN (p = 0"><entity charOffset="30-39" id="DDI-PubMed.29702137.s11.e0" text="VEN" /></sentence><sentence text="002, Cohen's d = 0,41; p = 0" /><sentence text="003, d = 0,44), respectively" /><sentence text=" Dose adjusted serum concentrations of active moiety and ODVEN revealed comparable differences (p = 0"><entity charOffset="59-61" id="DDI-PubMed.29702137.s14.e0" text="VEN" /></sentence><sentence text="038, d = 0,32; p = 0" /><sentence text="015, d = 0,28) with significantly higher values in the co-medicated group" /><sentence text=" Significantly higher values for ODVEN and AM suggest a reduced clearance of ODVEN and active moiety when quetiapine is co-administered"><entity charOffset="106-116" id="DDI-PubMed.29702137.s17.e0" text="quetiapine" /><entity charOffset="35-44" id="DDI-PubMed.29702137.s17.e1" text="VEN" /><entity charOffset="79-88" id="DDI-PubMed.29702137.s17.e2" text="VEN" /><pair ddi="false" e1="DDI-PubMed.29702137.s17.e1" e2="DDI-PubMed.29702137.s17.e1" /><pair ddi="false" e1="DDI-PubMed.29702137.s17.e1" e2="DDI-PubMed.29702137.s17.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s17.e1" e2="DDI-PubMed.29702137.s17.e0" /><pair ddi="false" e1="DDI-PubMed.29702137.s17.e2" e2="DDI-PubMed.29702137.s17.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s17.e2" e2="DDI-PubMed.29702137.s17.e0" /></sentence><sentence text=" This may be a consequence of a reduced metabolism of venlafaxine to the inactive metabolite N-desmethylvenlafaxine via CYP3A4, the main metabolizing enzyme for quetiapine, and a shift towards a higher proportion of the active metabolite ODVEN"><entity charOffset="54-65" id="DDI-PubMed.29702137.s18.e0" text="venlafaxine" /><entity charOffset="93-115" id="DDI-PubMed.29702137.s18.e1" text="N-desmethylvenlafaxine" /><entity charOffset="161-171" id="DDI-PubMed.29702137.s18.e2" text="quetiapine" /><entity charOffset="240-249" id="DDI-PubMed.29702137.s18.e3" text="VEN" /><pair ddi="false" e1="DDI-PubMed.29702137.s18.e0" e2="DDI-PubMed.29702137.s18.e0" /><pair ddi="false" e1="DDI-PubMed.29702137.s18.e0" e2="DDI-PubMed.29702137.s18.e1" /><pair ddi="false" e1="DDI-PubMed.29702137.s18.e0" e2="DDI-PubMed.29702137.s18.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s18.e0" e2="DDI-PubMed.29702137.s18.e3" /><pair ddi="false" e1="DDI-PubMed.29702137.s18.e1" e2="DDI-PubMed.29702137.s18.e1" /><pair ddi="false" e1="DDI-PubMed.29702137.s18.e1" e2="DDI-PubMed.29702137.s18.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s18.e1" e2="DDI-PubMed.29702137.s18.e3" /><pair ddi="false" e1="DDI-PubMed.29702137.s18.e2" e2="DDI-PubMed.29702137.s18.e2" /><pair ddi="false" e1="DDI-PubMed.29702137.s18.e2" e2="DDI-PubMed.29702137.s18.e3" /></sentence><sentence text=" Therapeutic drug monitoring is recommended in the case of co-medication to ensure clinical efficacy and patient safety" /><sentence text=" Although the increase of AM is moderate, we consider it relevant for clinicians given the prevalence of concomitant medication of quetiapine and venlafaxine"><entity charOffset="131-141" id="DDI-PubMed.29702137.s20.e0" text="quetiapine" /><entity charOffset="146-157" id="DDI-PubMed.29702137.s20.e1" text="venlafaxine" /><pair ddi="false" e1="DDI-PubMed.29702137.s20.e0" e2="DDI-PubMed.29702137.s20.e0" /><pair ddi="false" e1="DDI-PubMed.29702137.s20.e0" e2="DDI-PubMed.29702137.s20.e1" /></sentence><sentence text="" /></document>